DE69931633D1 - Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel - Google Patents

Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel

Info

Publication number
DE69931633D1
DE69931633D1 DE69931633T DE69931633T DE69931633D1 DE 69931633 D1 DE69931633 D1 DE 69931633D1 DE 69931633 T DE69931633 T DE 69931633T DE 69931633 T DE69931633 T DE 69931633T DE 69931633 D1 DE69931633 D1 DE 69931633D1
Authority
DE
Germany
Prior art keywords
mumbaistatin
medicament
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69931633T
Other languages
English (en)
Other versions
DE69931633T2 (de
Inventor
Nirogi Venkata Sat Ramakrishna
Keshavapura Hosamane Sre Swamy
Erra Koteswara Satya Vij Kumar
Manoj Maniram Singh Kushwaha
Sridevi Kota
Mythili Raman
Swati Dhananjay Tare
Sunil Kumar Deshmukh
Dietmar Schummer
Michael Kurz
Herbert Kogler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Sanofi Aventis Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland GmbH filed Critical Sanofi Aventis Deutschland GmbH
Publication of DE69931633D1 publication Critical patent/DE69931633D1/de
Application granted granted Critical
Publication of DE69931633T2 publication Critical patent/DE69931633T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69931633T 1998-06-24 1999-06-15 Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel Expired - Lifetime DE69931633T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98111636 1998-06-24
EP98111636 1998-06-24
PCT/EP1999/004127 WO1999067408A1 (en) 1998-06-24 1999-06-15 Mumbaistatin, a process for its production and its use as a pharmaceutical

Publications (2)

Publication Number Publication Date
DE69931633D1 true DE69931633D1 (de) 2006-07-06
DE69931633T2 DE69931633T2 (de) 2007-05-10

Family

ID=8232164

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69931633T Expired - Lifetime DE69931633T2 (de) 1998-06-24 1999-06-15 Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel

Country Status (17)

Country Link
US (1) US6297043B1 (de)
EP (1) EP1090136B1 (de)
JP (1) JP4287593B2 (de)
KR (1) KR20010071564A (de)
CN (1) CN1306580A (de)
AR (1) AR020328A1 (de)
AT (1) ATE328103T1 (de)
AU (1) AU750509B2 (de)
BR (1) BR9912200A (de)
CA (1) CA2336135A1 (de)
DE (1) DE69931633T2 (de)
HU (1) HUP0102370A3 (de)
ID (1) ID27411A (de)
PL (1) PL345192A1 (de)
RU (1) RU2221870C2 (de)
TR (1) TR200003570T2 (de)
WO (1) WO1999067408A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003512448A (ja) * 1999-10-25 2003-04-02 アベンティス・ファーマ・ドイチユラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 芳香族ジケト誘導体、その製造方法および医薬としてのその使用
US7659102B2 (en) 2001-02-21 2010-02-09 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
DK2333099T3 (da) 2001-02-21 2017-11-27 Basf Enzymes Llc Enzymer med alpha-amylase-aktivitet og fremgangsmåder til anvendelse deraf
US7741092B2 (en) 2002-10-31 2010-06-22 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
JP6465299B2 (ja) * 2015-05-29 2019-02-06 株式会社山田養蜂場本社 蜂蜜画分

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3905942A (en) 1973-06-22 1975-09-16 Gen Electric Method for making polyetherimides and products produced thereby
NL176369C (nl) * 1973-06-22 1985-04-01 Gen Electric Werkwijze ter bereiding van polyetherimiden, en voorwerpen daaruit vervaardigd.

Also Published As

Publication number Publication date
BR9912200A (pt) 2001-11-20
HUP0102370A3 (en) 2003-10-28
JP2002518057A (ja) 2002-06-25
AR020328A1 (es) 2002-05-08
AU750509B2 (en) 2002-07-18
PL345192A1 (en) 2001-12-03
TR200003570T2 (tr) 2001-04-20
DE69931633T2 (de) 2007-05-10
CA2336135A1 (en) 1999-12-29
KR20010071564A (ko) 2001-07-28
RU2221870C2 (ru) 2004-01-20
WO1999067408A1 (en) 1999-12-29
ID27411A (id) 2001-04-05
EP1090136A1 (de) 2001-04-11
US6297043B1 (en) 2001-10-02
AU4513799A (en) 2000-01-10
HUP0102370A2 (hu) 2001-10-28
JP4287593B2 (ja) 2009-07-01
EP1090136B1 (de) 2006-05-31
CN1306580A (zh) 2001-08-01
ATE328103T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
DE59712543D1 (de) Oxadiazole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE59508149D1 (de) Aerogelhaltiges verbundmaterial, verfahren zu seiner herstellung sowie seine verwendung
ATE302754T1 (de) Sulfonylcarboxamidderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50300813D1 (de) Neue fluorencarbonsaureester, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
DE59903878D1 (de) Aus mindestens drei komponenten bestehendes beschichtungsmittel, verfahren zu seiner herstellung sowie seine verwendung
DE60023023D1 (de) Zirkoniumdioxidsol und verfahren zu seiner herstellung
DE59608388D1 (de) Verstärktes formteil, verfahren zu seiner herstellung und seine verwendung
DE50101524D1 (de) Als arzneimittel einsetzbare anticholinergika sowie verfahren zu deren herstellung
DE59801636D1 (de) Tantalpulver, verfahren zu seiner herstellung, sowie daraus erhältliche sinteranoden
DE59801634D1 (de) Tantal-pulver, verfahren zu seiner herstellung, sowie daraus erhältliche sinteranoden
DE50013495D1 (de) Aus mindestens drei komponenten bestehender beschichtungsstoff, verfahren zu seiner herstellung sowie seine verwendung
DE59707078D1 (de) Monoolefinische c 5-mononitrile, verfahren zu ihrer herstellung und ihrer verwendung
DE59904493D1 (de) Aus mindestens drei komponenten bestehendes beschichtungsmittel, verfahren zu seiner herstellung sowie seine verwendung
DE60023747D1 (de) Hydantoin-, thiohydantoin-, pyrimidinedion- und thioxopyrimidinon-derivate, verfahren zur ihrer herstellung und ihre anwendung als arztneimittel
ATA155098A (de) Opto-chemischer sensor sowie verfahren zu seiner herstellung
DE50213372D1 (de) Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
DE59912311D1 (de) Aus mindestens drei komponenten bestehendes beschichtungsmittel, verfahren zu seiner herstellung sowie seine verwendung
ATE210638T1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE60029696D1 (de) Fluorierungsmittel, verfahren zu seiner herstellung und seine anwendung
DE50013410D1 (de) Substituierte norbornylamino-derivate, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
DE50011179D1 (de) Aminocarbonyl-substituierte benzimidazolderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE59912402D1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE69929126D1 (de) Formmaterial, seine benutzung als innenmaterial und verfahren zu seiner herstellung
DE69931633D1 (de) Mumbaistatin, verfahren zu seiner herstellung sowie seine verwendung als arzneimittel
DE59902408D1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament

Legal Events

Date Code Title Description
8364 No opposition during term of opposition